Compare PXED & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PXED | BLFS |
|---|---|---|
| Founded | 1976 | 1987 |
| Country | United States | United States |
| Employees | 3400 | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 923.5M |
| IPO Year | N/A | 2013 |
| Metric | PXED | BLFS |
|---|---|---|
| Price | $31.36 | $19.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $44.29 | $32.00 |
| AVG Volume (30 Days) | 65.5K | ★ 394.4K |
| Earning Date | 04-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $4.45 | $19.73 |
| Revenue Next Year | $4.66 | $17.82 |
| P/E Ratio | $11.20 | ★ N/A |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $23.52 | $17.86 |
| 52 Week High | $38.19 | $29.57 |
| Indicator | PXED | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 44.94 |
| Support Level | $29.78 | $17.86 |
| Resistance Level | $33.75 | $20.47 |
| Average True Range (ATR) | 1.58 | 0.80 |
| MACD | 0.41 | 0.15 |
| Stochastic Oscillator | 81.33 | 57.75 |
Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.